BioCentury
ARTICLE | Company News

Merrimack sales and marketing update

April 4, 2016 7:00 AM UTC

The 2016 National Comprehensive Cancer Network (NCCN) guidelines will include Merrimack’s Onivyde irinotecan ( MM-398) in combination with fluorouracil and leucovorin to treat metastatic pancreatic c...